marbofloxacin has been researched along with Swine Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Garch, F; Galland, D; Kroemer, S; Morrissey, I; Woehrle, F | 1 |
| Dorey, L; Lees, P | 1 |
| Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G | 1 |
| El Garch, F; Fraile, L; Giboin, H; Schneider, M; Vilalta, C | 1 |
| Dorey, L; Hobson, S; Lees, P | 2 |
| Aragon, V; Fraile, L; Galofré, N; Pérez de Rozas, AM; Vilalta, C | 1 |
| Gicquel-Bruneau, M; Laurentie, M; Pellet, T; Sanders, P | 1 |
| Davot, JL; Grandemange, E; Pommier, P; Thomas, E; Wessel-Robert, S | 1 |
1 trial(s) available for marbofloxacin and Swine Diseases
| Article | Year |
|---|---|
Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacteria; Body Temperature; Drug Evaluation; Europe; Fluoroquinolones; Injections, Intramuscular; Penicillins; Quinolones; Respiratory Tract Diseases; Solutions; Swine; Swine Diseases; Time Factors; Treatment Outcome | 2000 |
8 other study(ies) available for marbofloxacin and Swine Diseases
| Article | Year |
|---|---|
Survey of susceptibility to marbofloxacin in bacteria isolated from diseased pigs in Europe.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Microbial Sensitivity Tests; Swine; Swine Diseases; Treatment Outcome | 2017 |
Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Microbial Sensitivity Tests; Oxytetracycline; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Swine; Swine Diseases; Thiamphenicol | 2017 |
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol | 2015 |
Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Age Factors; Animals; Animals, Newborn; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus parasuis; Microbial Sensitivity Tests; Monte Carlo Method; Swine; Swine Diseases; Treatment Outcome | 2014 |
Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Topics: Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Area Under Curve; Culture Media; Fluoroquinolones; Microbial Sensitivity Tests; Pasteurella multocida; Pleuropneumonia; Swine; Swine Diseases | 2017 |
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia; Swine; Swine Diseases | 2017 |
Effect of marbofloxacin on Haemophilus parasuis nasal carriage.
Topics: Animals; Anti-Bacterial Agents; Fluoroquinolones; Haemophilus Infections; Haemophilus parasuis; Longitudinal Studies; Microbial Sensitivity Tests; Nose; Random Allocation; Swine; Swine Diseases | 2012 |
Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Poultry Diseases; Quinolones; Swine; Swine Diseases; Turkeys | 2006 |